
    
      Patients will be divided intro three groups, A control group will receive equivalent volume
      of glucose 10% solution both 3 days before and 5 days after the operation .

      A peri-operative groups, in which patients will receive omega 3 enriched lipid emulsion
      (SMOFLipid) for 2 days pre-transplantation and 5 days post-transplantation A Post-operative
      group, in which patients will receive glucose 10% 3 days before the operation and omega 3
      enriched lipid emulsion (SMOFLipid) for 5 days post-transplantation The primary outcome
      objective will be the incidence of Ischemia re-perfusion injury, secondary outcomes includes
      post-operative complications, graft and patient's outcomes and graft regeneration
    
  